SILO PHARMA, INC. Equity Method Investment, Summarized Financial Information, Net Income (Loss) (Deprecated 2020-01-31)
SILO PHARMA, INC. (SILO) reported Equity Method Investment, Summarized Financial Information, Net Income (Loss) (Deprecated 2020-01-31) of -$198.16 thousand for the 3-month period ending 2018-09-30, per its 10-Q filed 2018-11-14.
Discontinued › Income Statement › Other Income
us-gaap:EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss · last filed 2018-11-14
- SILO PHARMA, INC. equity method investment, summarized financial information, net income (loss) (deprecated 2020-01-31) for the quarter ending 2018-09-30 was -$198.16K.
- SILO PHARMA, INC. equity method investment, summarized financial information, net income (loss) (deprecated 2020-01-31) for the quarter ending 2017-09-30 was -$519.14K.
| Period end | Equity Method Investment, Summarized Financial Information, Net Income (Loss) (Deprecated 2020-01-31) 3 month | Equity Method Investment, Summarized Financial Information, Net Income (Loss) (Deprecated 2020-01-31) 9 month |
|---|---|---|
| 2018-09-30 | -$198.16K 10-Q · filed 2018-11-14 | -$496.53K 10-Q · filed 2018-11-14 |
| 2017-09-30 | -$519.14K 10-Q · filed 2018-11-14 | $149.65K 10-Q · filed 2018-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |